Coadministration of dolutegravir with boceprevir had no effect on dolutegravir area under the plasma concentration-time curve ( AUC ) and maximal plasma concentration ( Cmax ) and caused a small increase in concentration at the end of the dosing interval ( C ; 8 % ) .